SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/07/13 Pacira BioSciences, Inc. 10-K 12/31/12 87:9M Toppan Merrill-FA |
Document/Exhibit Description Pages Size 1: 10-K Annual Report HTML 979K 2: EX-10.47 Material Contract HTML 318K 3: EX-10.48 Material Contract HTML 163K 4: EX-21.1 Subsidiaries List HTML 20K 5: EX-23.1 Consent of Experts or Counsel HTML 25K 6: EX-31.1 Certification -- §302 - SOA'02 HTML 28K 7: EX-31.2 Certification -- §302 - SOA'02 HTML 28K 8: EX-32.1 Certification -- §906 - SOA'02 HTML 24K 9: EX-32.2 Certification -- §906 - SOA'02 HTML 24K 59: R1 Document and Entity Information HTML 51K 45: R2 Consolidated Balance Sheets HTML 144K 57: R3 Consolidated Balance Sheets (Parenthetical) HTML 49K 61: R4 Consolidated Statements of Operations HTML 90K 80: R5 Consolidated Statements of Comprehensive Loss HTML 48K 48: R6 Consolidated Statements of Stockholders' Equity HTML 135K (Deficit) 56: R7 Consolidated Statements of Cash Flows HTML 180K 41: R8 Business HTML 33K 31: R9 Summary of Significant Accounting Policies HTML 67K 81: R10 Recent Accounting Pronouncements HTML 26K 63: R11 Financial Instruments HTML 54K 62: R12 Inventories HTML 32K 68: R13 Fixed Assets HTML 38K 69: R14 Goodwill and Intangible Assets HTML 55K 66: R15 Accrued Expenses HTML 31K 70: R16 Debt HTML 51K 58: R17 Stockholders' Equity HTML 48K 60: R18 Stock Plans HTML 73K 65: R19 Earnings Per Share HTML 43K 87: R20 Cost of Revenues HTML 31K 76: R21 Income Taxes HTML 59K 52: R22 Other Employee Benefits HTML 25K 64: R23 Commercial Partners and Other Agreements HTML 35K 54: R24 Related Party Transactions HTML 35K 23: R25 Commitments and Contingencies HTML 42K 77: R26 Subsequent Events HTML 26K 84: R27 Summary of Significant Accounting Policies HTML 145K (Policies) 36: R28 Summary of Significant Accounting Policies HTML 40K (Tables) 35: R29 Financial Instruments (Tables) HTML 53K 39: R30 Inventories (Tables) HTML 29K 40: R31 Fixed Assets (Tables) HTML 33K 42: R32 Goodwill and Intangible Assets (Tables) HTML 52K 21: R33 Accrued Expenses (Tables) HTML 30K 74: R34 Debt (Tables) HTML 35K 50: R35 Stockholders' Equity (Tables) HTML 37K 53: R36 Stock Plans (Tables) HTML 77K 26: R37 Earnings Per Share (Tables) HTML 43K 86: R38 Cost of Revenues (Tables) HTML 30K 16: R39 Income Taxes (Tables) HTML 54K 43: R40 Commitments and Contingencies (Tables) HTML 29K 79: R41 Summary of Significant Accounting Policies HTML 29K (Details) 25: R42 Summary of Significant Accounting Policies HTML 43K (Details 2) 34: R43 Summary of Significant Accounting Policies HTML 31K (Details 3) 38: R44 Financial Instruments (Details) HTML 26K 46: R45 Financial Instruments (Details 2) HTML 47K 20: R46 Financial Instruments (Details 3) HTML 31K 30: R47 Inventories (Details) HTML 42K 18: R48 Fixed Assets (Details) HTML 52K 78: R49 Goodwill and Intangible Assets (Details) HTML 44K 24: R50 Goodwill and Intangible Assets (Details 2) HTML 59K 75: R51 Accrued Expenses (Details) HTML 36K 27: R52 Debt (Details) HTML 169K 44: R53 Stockholders' Equity (Details) HTML 61K 17: R54 Stockholders' Equity (Details 2) HTML 53K 19: R55 Stock Plans (Details) HTML 37K 37: R56 Stock Plans (Details 2) HTML 30K 22: R57 Stock Plans (Details 3) HTML 117K 82: R58 Earnings Per Share (Details) HTML 42K 49: R59 Earnings Per Share (Details 2) HTML 33K 67: R60 Cost of Revenues (Details) HTML 30K 29: R61 Income Taxes (Details) HTML 79K 32: R62 Income Taxes (Details 2) HTML 45K 73: R63 Other Employee Benefits (Details) HTML 25K 71: R64 Commercial Partners and Other Agreements (Details) HTML 29K 51: R65 Related Party Transactions (Details) HTML 60K 72: R66 Commitments and Contingencies (Details) HTML 63K 28: R67 Commitments and Contingencies (Details 2) HTML 33K 55: R68 Commitments and Contingencies (Details 3) HTML 32K 83: R69 Subsequent Events (Details) HTML 42K 85: XML IDEA XML File -- Filing Summary XML 125K 33: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 909K 10: EX-101.INS XBRL Instance -- pcrx-20121231 XML 1.48M 12: EX-101.CAL XBRL Calculations -- pcrx-20121231_cal XML 258K 15: EX-101.DEF XBRL Definitions -- pcrx-20121231_def XML 769K 13: EX-101.LAB XBRL Labels -- pcrx-20121231_lab XML 3.14M 14: EX-101.PRE XBRL Presentations -- pcrx-20121231_pre XML 1.39M 11: EX-101.SCH XBRL Schema -- pcrx-20121231 XSD 250K 47: ZIP XBRL Zipped Folder -- 0001047469-13-002336-xbrl Zip 232K
Page | (sequential) | (alphabetic) | ↑Top | ||
---|---|---|---|---|---|
1 | 1st Page – Filing Submission | ||||
" | Exhibit 32.1 | ||||
" | Statement Pursuant to 18 U.S.C. S1350 | ||||
" | QuickLinks |
STATEMENT PURSUANT TO 18 U.S.C. §1350
Pursuant to 18 U.S.C. §1350, the undersigned certifies that this Annual Report on Form 10-K of Pacira Pharmaceuticals, Inc. for the year ended December 31, 2012, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in this report fairly presents, in all material respects, the financial condition and results of operations of Pacira Pharmaceuticals, Inc.
Date: March 7, 2013 | /s/ DAVID STACK David Stack President and Chief Executive Officer (Principal Executive Officer) |
This ‘10-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 3/7/13 | 4, 4/A, 8-K | ||
For Period end: | 12/31/12 | ARS | ||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 12/13/13 SEC UPLOAD¶ 9/20/17 1:34K Pacira BioSciences, Inc. 12/02/13 SEC UPLOAD¶ 9/20/17 1:153K Pacira BioSciences, Inc. |